Mintz Steven's Form 4 filing
Serina Therapeutics, Inc. (SER) · filed Jun 27, 2024
- Accession no.
- 0001493152-24-025498
- Filed
- Jun 27, 2024
- Trade date
- Jun 21-25, 2024
- Filing delay
- 6 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $70.9K. It was filed 6 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mintz StevenCIK 0002008741 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 21, 2024 | Common Stock | PPurchaseAcquired | +5,000 | $9.50 | +$47,500 | 8,307 | Direct | |
| Jun 25, 2024 | Common Stock | PPurchaseAcquired | +2,600 | $9.00 | +$23,400 | 10,907 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.